Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended Regional Anesthesia to Prevent Chronic Pain After Ankle Fracture Surgery
NCT02950558Phase 4Completed
- Sponsor
- University of Cincinnati
- Start
- May 2018
- Primary completion
- Nov 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ropivacaine in chronic pain (2 arms), sponsored by University of Cincinnati. Primary endpoint: Pain Score at 12 Months. Started May 2018; status: completed.
02
Drugs
ropivacaine
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT02950558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02950558.